IlDong Pharmaceutical Co Ltd   Report issue

Founded: Seoul Korea, Republic of (1941)
Status: No NME R&D (1941)

Organization Overview

First Clinical Trial
2012
NCT01769157
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Idience Co., Ltd. | IlDong Pharmaceutical Co Ltd